Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $14.87 $19.38 Friday, 10th May 2024 RGNX stock ended at $15.44. This is 1.53% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 10.42% from a day low at $14.87 to a day high of $16.42.
90 days $14.87 $28.80
52 weeks $11.83 $28.80

Historical REGENXBIO Inc. prices

Date Open High Low Close Volume
Feb 29, 2024 $20.39 $20.48 $17.13 $17.44 1 049 260
Feb 28, 2024 $19.01 $20.04 $18.33 $19.90 1 058 427
Feb 27, 2024 $18.61 $20.28 $18.61 $20.02 980 395
Feb 26, 2024 $17.48 $18.77 $17.48 $18.34 711 901
Feb 23, 2024 $18.21 $18.43 $17.19 $17.41 600 908
Feb 22, 2024 $18.41 $18.99 $17.94 $18.17 436 440
Feb 21, 2024 $18.84 $18.90 $17.85 $18.40 331 454
Feb 20, 2024 $18.68 $19.80 $18.27 $18.54 378 739
Feb 16, 2024 $18.36 $20.34 $18.25 $18.83 987 125
Feb 15, 2024 $16.92 $18.64 $16.92 $18.45 759 658
Feb 14, 2024 $16.40 $17.27 $15.87 $16.79 569 168
Feb 13, 2024 $16.57 $16.75 $15.81 $16.04 719 203
Feb 12, 2024 $16.29 $17.81 $16.29 $17.36 716 609
Feb 09, 2024 $16.87 $18.10 $16.02 $16.21 1 884 157
Feb 08, 2024 $14.55 $16.38 $14.13 $16.29 1 069 504
Feb 07, 2024 $13.51 $15.49 $13.51 $14.57 1 797 839
Feb 06, 2024 $12.26 $13.09 $12.05 $13.05 285 263
Feb 05, 2024 $12.06 $12.42 $11.89 $12.32 393 511
Feb 02, 2024 $12.45 $12.68 $11.83 $12.24 435 066
Feb 01, 2024 $12.33 $12.82 $12.06 $12.68 596 592
Jan 31, 2024 $12.24 $12.85 $12.23 $12.32 559 417
Jan 30, 2024 $12.85 $12.85 $12.08 $12.17 387 922
Jan 29, 2024 $12.70 $13.08 $12.43 $12.97 336 504
Jan 26, 2024 $13.43 $13.57 $12.65 $12.72 253 598
Jan 25, 2024 $14.15 $14.33 $13.20 $13.26 323 917
Click to get the best stock tips daily for free!

About REGENXBIO Inc.

REGENXBIO. REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's lead product candidate is RGX-314, wh... RGNX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT